Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors.AuthorsAdjei, Alex; LoRusso, Patricia; Ribas, Antoni; Sosman, Jeffrey; Pavlick, Anna; Dy, Grace; Zhou, Xiaofei; Gangolli, Esha; Kneissl, Michelle; Faucette, Stephanie; Neuwirth, Rachel; Bózon, VivianaPublicationInvestigational New Drugs, 2017, Vol 35, Issue 1, p47ISSN0167-6997Publication typeArticleDOI10.1007/s10637-016-0391-2